Results 111 to 120 of about 1,233,950 (356)

Construction and Test of MDT Chambers for the ATLAS Muon Spectrometer

open access: yes, 2016
The Monitored Drift Tube (MDT) chambers for the muon spectrometer of the AT- LAS detector at the Large Hadron Collider (LHC) consist of 3-4 layers of pressurized drift tubes on either side of a space frame carrying an optical monitoring system to correct
Bauer, F.   +14 more
core   +1 more source

Actionable Wearables Data for the Neurology Clinic: A Proof‐of‐Concept Tool

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Wearable devices can monitor key health and fitness domains. In multiple sclerosis (MS), monitoring step count and sleep is feasible, valid, and offers a holistic glimpse of patient functioning and worsening. However, data generated from wearables are typically unavailable at the point of care.
Nicolette Miller   +12 more
wiley   +1 more source

Chromatic dispersion monitoring for high-speed WDM systems using two-photon absorption in a semiconductor microcavity [PDF]

open access: yes, 2009
This paper presents a theoretical and experimental investigation into the use of a two-photon absorption (TPA) photodetector for use in chromatic dispersion (CD) monitoring in high-speed, WDM network. In order to overcome the inefficiency associated with
Barry, Liam P.   +8 more
core   +1 more source

SARS‐CoV‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The impact of SARS‐CoV‐2 infection on brain and spinal cord pathology in patients with multiple sclerosis (pwMS) remains unclear. We aimed to describe changes in brain lesion activity and brain and spinal cord volumes following SARS‐CoV‐2 infection.
Tomas Uher   +12 more
wiley   +1 more source

Simultaneous chromatic dispersion, polarization-mode-dispersion and OSNR monitoring at 40Gbit/s [PDF]

open access: yes, 2008
A novel method for independent and simultaneous monitoring of chromatic dispersion ( CD), first-order PMD and OSNR in 40Gbit/s systems is proposed and demonstrated.
Baker-Meflah, L   +3 more
core   +1 more source

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan   +8 more
wiley   +1 more source

Performance monitoring of long chains of optical amplifiers

open access: yesElectronics Letters, 1993
The monitoring and fault location of long chains of optical amplifiers such as will be deployed in undersea cable systems is an important design consideration. The Letter describes two methods which have been proposed and one which has been evaluated on our test bed simulator of 3100 km with OAs spaced at 45 km and operating at 5 Gbit/s.
I.J. Hirst, J. Brannan, A.J. Jeal
openaire   +2 more sources

Cognitive and Patient‐Reported Outcome Measures in LGI‐1‐IgG Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical outcome measures for autoimmune encephalitis (AE) are not yet well defined. Cognitive outcome measures (CogOs) and patient‐reported outcomes (PROs) may capture the symptoms of AE, beyond clinician‐reported outcomes (ClinROs) (the Modified Rankin Scale [mRS] and Clinical Assessment Scale in Autoimmune Encephalitis [CASE ...
Tatchaporn Ongphichetmetha   +8 more
wiley   +1 more source

Enhancing the Credibility of the Optical Performance Monitor With Adversarial Training [PDF]

open access: gold, 2020
Xiaojie Fan   +8 more
openalex   +1 more source

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy